RAPAd®

The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

Request Quote

Confidentiality

 

Learn More

Quality Control

Plaque forming units guarantee. Non-detectable RCA.

Learn More

Turnaround Time

Sub-cloning to finished particles in about four weeks.

Learn More

Dual Expressers

Multiple transgene expression in a single virus.

Learn More

Yearly Archives: 2010

Akt activation emulates Chk1 inhibition and Bcl2 overexpression and abrogates G2 cell cycle checkpoint by inhibiting BRCA1 foci.

Authors: Tonic I, Yu WN, Park Y, Chen CC, Hay N.
Citation: J Biol Chem. 2010 Jul 30;285(31):23790-8.

read more

Protein phosphatase 2A (PP2A) holoenzymes regulate death-associated protein kinase (DAPK) in ceramide-induced anoikis.

Authors: Widau RC, Jin Y, Dixon SA, Wadzinski BE, Gallagher PJ.
Citation: J Biol Chem. 2010 Apr 30;285(18):13827-38.

read more

Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha).

Authors: Attia RR, Connnaughton S, Boone LR, Wang F, Elam MB, Ness GC, Cook GA, Park EA.
Citation: J Biol Chem. 2010 Jan 22;285(4):2375-85.

read more

MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.

Authors: Lu H, Buchan RJ, Cook SA.
Citation: Cardiovasc Res. 2010 Jun 1;86(3):410-20.

read more

Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA.

Authors: Gabitzsch ES, Xu Y, Balint JP Jr, Hartman ZC, Lyerly HK, Jones FR.
Citation: Cancer Immunol Immunother. 2010 Jul;59(7):1131-5.

read more

A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.

Authors: Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC.
Citation: Gene Ther. 2010 Nov;17(11):1325-32.

read more

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.

Authors: Harvey TJ, Burdon D, Steele L, Ingram N, Hall GD, Selby PJ, Vile RG, Cooper PA, Shnyder SD, Chester JD.
Citation: Gene Ther. 2010 Aug;17(8):1000-10.

read more